The elimination of mycoplasma from infected hybridomas by passaging in BALB/c mice

Journal of Immunological Methods - Tập 108 - Trang 189-193 - 1988
Kenneth Carroll1, Richard O'Kennedy1
1School of Biological Sciences, National Institute for Higher Education, Glasnevin, Dublin 9, Ireland

Tài liệu tham khảo

Adams, 1980, 128 Campbell, 1980, 110 Carroll, 1984, Solid phase enzyme linked immunosorbant assay for the large scale screening of hybridomas: non-specific effects and their solutions, Biochem. Soc. Trans., 13, 473, 10.1042/bst0130473 Chen, 1977, In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain, Exp. Cell Res., 104, 255, 10.1016/0014-4827(77)90089-1 Duc-Nguyen, 1966, Persistent infection of a rat kidney cell line with Rauscher murine leukemia virus, J. Bacteriol., 92, 1133, 10.1128/jb.92.4.1133-1140.1966 Gillette, 1987, Alternatives to pristane for ascitic fluid and monoclonal antibody production, J. Immunol. Methods, 99, 21, 10.1016/0022-1759(87)90027-5 Hessling, 1980, A direct comparison of procedures for the detection of mycoplasma in tissue culture, J. Immunol. Methods, 38, 315, 10.1016/0022-1759(80)90280-X Littefield, 1964, Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinations, Science, 145, 709, 10.1126/science.145.3633.709 Mueller, 1986, Monoclonal antibody production by hybridoma growth in Freund's adjuvant primed mice, J. Immunol. Methods, 87, 193, 10.1016/0022-1759(86)90530-2 Schmidt, 1984, Elimination of mycoplasma from cell cultures, Exp. Cell Res., 152, 565, 10.1016/0014-4827(84)90659-1 Smith, 1971, The Biology of Mycoplasmas, 1 Stewart, 1969, In vitro sensitivity of strains of mycoplasma from human sources to antibiotics and to sodium aurothiomalate and tylosin tartrate, J. Med. Microbiol., 2, 287, 10.1099/00222615-2-3-287 Van, 1977, Reduction in cellular tumorgeneity after mycoplasma infection and elimination of mycoplasma from cultures by passage in nude mice, Cancer Res., 37, 2680 Westerwoudt, 1985, Improved fusion methods. IV. Technical aspects, J. Immunol. Methods, 77, 181, 10.1016/0022-1759(85)90031-6